Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical outcomes and safety of the immune checkpoint inhibitor rechallenge in Hodgkin lymphoma: an off-trial analysis.

Immune checkpoint inhibitors (ICIs) are effective in classical Hodgkin lymphoma (cHL), but immune-related adverse events (irAEs) may lead to treatment interruption in some patients. We conducted a retrospective cohort study of 145 patients with cHL treated with ICIs between 2015 and 2024. Cohort 1 included 130 patients...

Yoshito Nishimura, Joey Maiocco, Guneet Janda et al. · 0 citations
Review Open access Sep 2026

Impact of a Virtual Multidisciplinary Lymphoma Tumor Board on Clinical Decision-Making

Objective To evaluate the impact of a virtual multidisciplinary lymphoma tumor board on clinical decision-making over time. Patients and Methods The Mayo Clinic Lymphoma Tumor Board, part of the International Mayo Clinic Care Network, conducted a retrospective review of 722 cases from January 1, 2014 to July 31,2024. T...

I. Okcu, U. Durani, Robert J. Levy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.